Article info
PDFCurrent controversy
Ethical concerns with online direct-to-consumer pharmaceutical companies
- Correspondence to Henry Curtis, Philosophy, SUNY Albany, Albany, NY 12222, USA; hcurtis{at}albany.edu
Citation
Ethical concerns with online direct-to-consumer pharmaceutical companies
Publication history
- Received August 23, 2019
- Revised October 29, 2019
- Accepted November 13, 2019
- First published November 28, 2019.
Online issue publication
February 21, 2020
Article Versions
- Previous version (28 November 2019).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.
Other content recommended for you
- Influence and management of conflicts of interest in randomised clinical trials: qualitative interview study
- Financial conflicts of interest among US physician authors of 2020 clinical practice guidelines: a cross-sectional study
- Conflicts of interest and spin in reviews of psychological therapies: a systematic review
- Ethics and Technology Transfer
- Commercial influence and the content of medical journals
- Conflict of interest in online point-of-care clinical support websites
- Conflict of interest policies and disclosure requirements among European Society of Cardiology national cardiovascular journals
- Association between conflicts of interest and favourable recommendations in clinical guidelines, advisory committee reports, opinion pieces, and narrative reviews: systematic review
- Mandatory disclosure of financial interests of journals and editors
- Direct to consumer advertising